1.Fertility preservation in the management of gynecologic cancers.
Jun-jun YANG ; Yang XIANG ; Keng SHEN
Acta Academiae Medicinae Sinicae 2003;25(4):476-480
Cancer treatment has improved the rate of survival associated with neoplasias, and cancer survivors are more and more interested in preserving fertility potential. This article focuses on new and innovative techniques as well as approaches to treat gynecologic cancers while minimizing the negative fertility effects of cancer treatment. In particular, the radical trachelectomy procedure in cervical cancer, hormonal treatment of early endometrial cancer, conservative surgical management of early-stage epithelial ovarian cancer, and novel assisted reproductive technologies for women with impaired ovarian function after cancer treatment are discussed.
Adult
;
Carcinoma, Squamous Cell
;
therapy
;
Cryopreservation
;
Endometrial Neoplasms
;
therapy
;
Female
;
Fertility
;
Humans
;
Infertility, Female
;
prevention & control
;
Ovarian Neoplasms
;
therapy
;
Ovary
;
Uterine Cervical Neoplasms
;
therapy
2.Gonadal damage and options for fertility preservation in female and male cancer survivors.
Theodoros MALTARIS ; Heinz KOELBL ; Rudolf SEUFERT ; Franklin KIESEWETTER ; Matthias W BECKMANN ; Andreas MUELLER ; Ralf DITTRICH
Asian Journal of Andrology 2006;8(5):515-533
It is estimated that in 2010, 1 in every 250 adults will be a childhood cancer survivor. Today, oncological surgery, radiotherapy and chemotherapy achieve relatively high rates of remission and long-term survival, yet are often detrimental to fertility. Quality of life is increasingly important to long-term survivors of cancer, and one of the major quality-of-life issues is the ability to produce and raise normal children. Developments in the near future in the emerging field of fertility preservation in cancer survivors promise to be very exciting. This article reviews the published literature, discusses the effects of cancer treatment on fertility and presents the options available today thanks to advances in assisted-reproduction technology for maintaining fertility in male and female patients undergoing this type of treatment. The various diagnostic methods of assessing the fertility potential and the efficacy of in vitro fertilization (IVF) after cancer treatment are also presented.
Adult
;
Child
;
Female
;
Fertility
;
Humans
;
Infertility
;
prevention & control
;
Male
;
Neoplasms
;
drug therapy
;
radiotherapy
;
surgery
;
Ovarian Neoplasms
;
pathology
;
Ovary
;
pathology
;
Survivors
;
Testicular Neoplasms
;
pathology
;
Testis
;
pathology
3.Benefits of nursing care service in the assisted reproduction clinic to self-cycle-management and self-efficiency of infertility patients.
Xiao-Qin LI ; Chao-Feng SUN ; Mei GUO
National Journal of Andrology 2017;23(6):536-539
Objective:
To investigate the benefits of nursing care service in the assisted reproduction clinic to self-cycle-management and self-efficiency of the outpatients with infertility.
METHODS:
We randomly divided 600 females preliminarily diagnosed with infertility into a control and an experimental group, 288 in the former and 285 in the latter group excluding those whose husbands had azoospermia. For the women patients of the experimental group, we conducted nursing care intervention concerning related knowledge, skills, diet, excise, medication, and psychology, by one-to-one consultation, individualized or group communication, establishing files, telephone follow-up, and wechat guidance. After 3 months of intervention, we compared the compliance of medical visits, effectiveness of cycle management, sense of self-efficiency, satisfaction, and anxiety score between the two groups of patients.
RESULTS:
In comparison with the controls, the patients of the experimental group showed significantly better knowledge about assisted reproduction and higher effectiveness of self-cycle-management, self-efficiency, and satisfaction (P <0.05), but a markedly lower degree of anxiety (P <0.05).
CONCLUSIONS
Nursing care service in the assisted reproduction clinic can improve the compliance of medical visits, effectiveness of self-cycle-management, self-efficiency, and satisfaction and reduce the anxiety of the patients.
Anxiety
;
prevention & control
;
Diet
;
Exercise
;
Female
;
Health Knowledge, Attitudes, Practice
;
Humans
;
Infertility
;
nursing
;
psychology
;
Menstrual Cycle
;
Patient Compliance
;
Patient Satisfaction
;
Reproductive Techniques, Assisted
;
psychology
;
Self Efficacy
4.Controversies in borderline ovarian tumors.
Seok Ju SEONG ; Da Hee KIM ; Mi Kyoung KIM ; Taejong SONG
Journal of Gynecologic Oncology 2015;26(4):343-349
Borderline ovarian tumors (BOTs) represent about 15% to 20% of all ovarian malignancies and differ from invasive ovarian cancers (IOCs) by many characters. Historically, standard management of BOT is peritoneal washing cytology, hysterectomy, bilateral salpingo-oophorectomy, omentectomy, complete peritoneal resection of macroscopic lesions; in case of mucinous BOTs, appendectomy should be performed. Because BOTs are often diagnosed at earlier stage, in younger age women and have better prognosis, higher survival rate than IOCs, fertility-sparing surgery is one of the option to preserve childbearing capacity. The study of such conservative surgery is being released, and still controversial. After surgery, pregnancy and ovarian induction followed by in vitro fertilization are also significant issues. In surgery, laparoscopic technique can be used by a gynecologic oncology surgeon. So far postoperative chemotherapy, radiotherapy and hormone therapy are not recommended. We will discuss controversial issues of BOTs on this review and present the outline of the management of BOTs.
Biopsy
;
Chemotherapy, Adjuvant
;
Female
;
Humans
;
Infertility, Female/prevention & control
;
Intraoperative Care/methods
;
Laparoscopy/methods
;
Laparotomy/methods
;
Neoplasm Recurrence, Local/therapy
;
Neoplasm Staging
;
Organ Sparing Treatments/methods
;
Ovarian Neoplasms/pathology/*therapy
;
Ovary/*pathology
;
Precancerous Conditions/pathology/therapy
5.Possibility of women treated with fertility-sparing surgery for non-epithelial ovarian tumors to safely and successfully become pregnant-a Chinese retrospective cohort study among 148 cases.
Bin YANG ; Yan YU ; Jing CHEN ; Yan ZHANG ; Ye YIN ; Nan YU ; Ge CHEN ; Shifei ZHU ; Haiyan HUANG ; Yongqun YUAN ; Jihui AI ; Xinyu WANG ; Kezhen LI
Frontiers of Medicine 2018;12(5):509-517
This study was performed to evaluate the oncological and reproductive outcomes of childbearing-age women treated with fertility-sparing surgery (FSS) for non-epithelial ovarian tumors in China. One hundred and forty eight non-epithelial ovarian tumor women treated with FSS between January 1, 2000 and August 31, 2015 from two medical centers in China were identified. Progression-free survival (PFS) was 88.5%, whereas overall survival (OS) was 93.9%. Univariate analysis suggested that delivery after treatment is related to PFS (P = 0.023), whereas histology significantly influenced OS. Cox regression analysis suggested that only histology was associated with PFS and OS (P < 0.05). Among the 129 women who completed adjuvant chemotherapy (ACT), none developed amenorrhea. Among the 44 women who desired pregnancy, 35 (79.5%) successfully had 51 gestations including 35 live births without birth defects. Non-epithelial ovarian tumors can achieve fulfilling prognosis after FSS and chemotherapy. Histology might be the only independent prognostic factor for PFS and OS. FSS followed by ACT appeared to have little or no effect on fertility. Meanwhile, postoperative pregnancy did not increase the PFS or OS. Use of gonadotropin-releasing hormone agonist was not beneficial for fertility.
Adolescent
;
Adult
;
Chemotherapy, Adjuvant
;
adverse effects
;
Child
;
China
;
Female
;
Humans
;
Infertility, Female
;
etiology
;
prevention & control
;
Neoplasm Staging
;
Organ Sparing Treatments
;
Ovarian Neoplasms
;
drug therapy
;
surgery
;
Pregnancy
;
Pregnancy Rate
;
Prognosis
;
Retrospective Studies
;
Survival Analysis
;
Young Adult
6.Human papillomavirus infection and male reproductive health.
National Journal of Andrology 2017;23(4):376-380
Human papillomavirus (HPV) infection is one of the worldwide sexually transmitted diseases (STD), and the DNA of HPV can exist in the normal epithelium of reproductive organs of both men and women. Because the majority of HPV infections are asymptomatic, healthy HPV-carriers become the main source of the infection. Studies show that HPV infection in men is correlated with STD, infertility, tumor of reproductive organs, and infection in the sexual partners. Therefore, measures should be taken to reduce male HPV infection, including circumcision, fewer sexual partners, and condom use.
Adult
;
Asymptomatic Infections
;
Carrier State
;
virology
;
Circumcision, Male
;
Female
;
Humans
;
Infertility, Male
;
virology
;
Male
;
Papillomaviridae
;
Papillomavirus Infections
;
complications
;
prevention & control
;
transmission
;
Reproductive Health
;
Risk Factors
;
Sexual Partners
;
Sexually Transmitted Diseases
;
virology
7.Preimplantation genetic diagnosis for infertile males with autosomal dominant polycystic kidney disease.
Xiao-Yu YANG ; Tao LI ; Xiao-Jun LIU ; Jian-Dong SHEN ; Yu-Gui CUI ; Gui-Rong ZHANG ; Jia-Yin LIU
National Journal of Andrology 2018;24(5):409-413
ObjectiveAutosomal dominant polycystic kidney disease (ADPKD) is one of the most common genetic renal diseases, which may cause oligoasthenospermia and azoospermia and result in male infertility. This study aimed to analyze the outcomes of preimplantation genetic diagnosis (PGD) in male patients with ADPKD-induced infertility.
METHODSWe retrospectively analyzed the clinical data on 7 male patients with ADPKD-induced infertility undergoing PGD from April 2015 to February 2017, including 6 cases of oligoasthenospermia and 1 case of obstructive azoospermia, all with the PKD1 gene heterozygous mutations. Following intracytoplasmic sperm injection (ICSI), we performed blastomere biopsy after 5 or 6 days of embryo culture and subjected the blastomeres to Sureplex whole-genome amplification, followed by haplotype linkage analysis, Sanger sequencing, array-based comparative genomic hybridization to assess the chromosomal ploidy of the unaffected embryos, and identification of the unaffected euploid embryos for transfer.
RESULTSOne PGD cycle was completed for each of the 7 patients. Totally, 26 blastocysts were developed, of which 12 were unaffected and diploid. Clinical pregnancies were achieved in 6 cases following 7 cycles of frozen embryo transplantation, which included 5 live births and 1 spontaneous abortion.
CONCLUSIONSFor males with ADPKD-induced infertility, PGD may contribute to high rates of clinical pregnancy and live birth and prevent ADPKD in the offspring as well. This finding is also meaningful for the ADPKD patients with normal fertility.
Abortion, Spontaneous ; genetics ; Biopsy ; Blastocyst ; Comparative Genomic Hybridization ; Embryo Transfer ; Female ; Humans ; Infertility, Male ; etiology ; genetics ; Male ; Mutation ; Polycystic Kidney, Autosomal Dominant ; complications ; diagnosis ; genetics ; prevention & control ; Pregnancy ; Pregnancy Outcome ; Preimplantation Diagnosis ; Retrospective Studies ; Sperm Injections, Intracytoplasmic
8.Minimum dose of hCG to trigger final oocyte maturation and prevent OHSS in a long GnRHa protocol.
Xin CHEN ; Shi-ling CHEN ; Yu-xia HE ; De-sheng YE
Journal of Huazhong University of Science and Technology (Medical Sciences) 2013;33(1):133-136
This paper was aimed to study the minimum dose of human chorionic gonadotropin (hCG) to effectively trigger maturation of oocytes and prevent ovarian hyperstimulation syndrome (OHSS) in a series of hyper-responders treated with a long gonadotropin releasing hormone agonist (GnRHa) protocol. Six women at high risk of developing severe OHSS in a long GnRHa protocol were enrolled into this study. Serum hormone levels on the day of and after hCG administration, antral follicle count, oocyte retrieval number and quality were determined. In total, 6 women aged between 29 and 36 years and at risk of developing severe OHSS, received 2000 U hCG. Five of them were treated with coasting for 1 day and the rest one for 4 days. The mean number of oocytes collected was 19 (range 14-27) and the fertilization rate per collected oocyte was 72.81%. Of the 6 women in the study, only one cancelled embryos transfer and all embryos were frozen, and then she delivered two health boys on term in the subsequent frozen-thawed embryo transfer (FET) cycle. Pregnancies and births were achieved in 3 patients out of 5 in vitro fertilization-embryo transfer (IVF-ET) cycles. No woman developed moderate or severe OHSS. Triggering with 2000 U hCG is feasible to prevent OHSS in unpredicted hyper-responders undergoing IVF in a long GnRHa protocol.
Adult
;
Chorionic Gonadotropin
;
administration & dosage
;
adverse effects
;
Dose-Response Relationship, Drug
;
Female
;
Fertility Agents, Female
;
administration & dosage
;
Gonadotropin-Releasing Hormone
;
antagonists & inhibitors
;
Humans
;
Infertility, Female
;
therapy
;
Oocytes
;
drug effects
;
pathology
;
Ovarian Hyperstimulation Syndrome
;
etiology
;
prevention & control
;
Ovulation Induction
;
adverse effects
;
methods
;
Treatment Outcome
9.Clinical observation on treatment of Stein-Leventhal syndrome caused sterility by combined use of clomiphene and Chinese nourishing shen and activating blood circulation drugs.
Rui-yun SHAO ; Feng-jun LANG ; Jin-feng CAI
Chinese Journal of Integrated Traditional and Western Medicine 2004;24(1):41-43
OBJECTIVETo observe the efficacy of combination therapy of clomiphene and Chinese drugs for nourishing Shen and activating blood circulation (NSABC) in treating Stein-Leventhal syndrome caused sterility.
METHODSSixty-two patients with anovulation caused sterility were randomly divided into the treated group (n = 32) and the control group (n = 30). The treated grop was treated with the combination therapy and the control group treated by the same dosage of clomiphene alone.
RESULTSAfter treatment, when comparing with that before treatment, the endocrine hormones in the treated group improved significantly, showing a markedly decrease of androgen and luteotropic hormone, and increase of estrogen (P < 0.001). The periodic ovulation rate in the treated group reached 87%, the total pregnancy rate being 65.6%, with no occurrence of ovarian hyperstimulation syndrome (OHSS) and luteinized unruptured follicle syndrome (LUFS), while in the control group, the periodic ovulation rate was 66%, the total pregnancy rate 36.6%, with LUFS occurred in 4 patients. Comparison of the therapeutic effects between the two groups showed significant difference (P < 0.05).
CONCLUSIONThe combination therapy of clomiphene and NSABC has a better therapeutic effect in treating Stein-Leventhal syndrome caused sterility than that of using clomiphene alone.
Adult ; Androgens ; blood ; Anovulation ; blood ; etiology ; Clomiphene ; therapeutic use ; Drug Therapy, Combination ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Humans ; Infertility, Female ; blood ; drug therapy ; etiology ; Ovarian Hyperstimulation Syndrome ; prevention & control ; Ovulation Induction ; Phytotherapy ; Polycystic Ovary Syndrome ; blood ; complications ; drug therapy ; Progestins ; blood
10.Fertility sparing surgery in early stage epithelial ovarian cancer.
Antonino DITTO ; Fabio MARTINELLI ; Domenica LORUSSO ; Edward HAEUSLER ; Marialuisa CARCANGIU ; Francesco RASPAGLIESI
Journal of Gynecologic Oncology 2014;25(4):320-327
OBJECTIVE: Fertility sparing surgery (FSS) is a strategy often considered in young patients with early epithelial ovarian cancer. We investigated the role and the outcomes of FSS in eEOC patients who underwent comprehensive surgery. METHODS: From January 2003 to January 2011, 24 patients underwent fertility sparing surgery. Eighteen were one-to-one matched and balanced for stage, histologic type and grading with a group of patients who underwent radical comprehensive staging (n=18). Demographics, surgical procedures, morbidities, pathologic findings, recurrence-rate, pregnancy-rate and correlations with disease-free survival were assessed. RESULTS: A total of 36 patients had a complete surgical staging including lymphadenectomy and were therefore analyzed. Seven patients experienced a recurrence: four (22%) in the fertility sparing surgery group and three (16%) in the control group (p=not significant). Sites of recurrence were: residual ovary (two), abdominal wall and peritoneal carcinomatosis in the fertility sparing surgery group; pelvic (two) and abdominal wall in the control group. Recurrences in the fertility sparing surgery group appeared earlier (mean, 10.3 months) than in radical comprehensive staging group (mean, 53.3 months) p<0.001. Disease-free survival were comparable between the two groups (p=0.422). No deaths were reported. All the patients in fertility sparing surgery group recovered a regular period. Thirteen out of 18 (72.2%) attempted to have a pregnancy. Five (38%) achieved a spontaneous pregnancy with a full term delivery. CONCLUSION: Fertility sparing surgery in early epithelial ovarian cancer submitted to a comprehensive surgical staging could be considered safe with oncological results comparable to radical surgery group.
Adult
;
Female
;
Fertility
;
Fertility Preservation/*methods
;
Humans
;
Infertility, Female/prevention & control
;
Lymph Node Excision
;
Lymphatic Metastasis
;
Middle Aged
;
Neoplasm Recurrence, Local
;
Neoplasm Staging
;
Neoplasms, Glandular and Epithelial/pathology/*surgery
;
Ovarian Neoplasms/pathology/*surgery
;
Pregnancy
;
Pregnancy Outcome
;
Retrospective Studies
;
Survival Analysis
;
Treatment Outcome
;
Young Adult